J Young Pharm. 2010 Apr;2(2):116-20. doi: 10.4103/0975-1483.63144.

Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug Delivery.

Journal of young pharmacists : JYP

Dh Shastri, Ld Patel, Rk Parikh

PMID: 21264112 PMCID: PMC3021684 DOI: 10.4103/0975-1483.63144

Abstract

The present work describes the formulation development of ophthalmic in situ gelling system using thermo-reversible gelling polymer, i.e. Pluronic F 127 (PF127). Because of high concentration (20 to 25%w/v) of this polymer required for in situ gelation causes irritation to the eye. So, to reduce this concentration, an attempt was made to combine the PF127 with other polymers like hydroxy propyl methyl cellulose (HPMC) as a viscosity increasing agent or with polymers like carbopol 940, xanthan gum, and sodium alginate (high glucuronic acid content) showing a pH and cation-triggered sol-gel transition, respectively. Different batches were prepared of varying concentrations of these polymers with PF127 using cromolyn sodium 2%w/v in phosphate buffer pH 5.0. The formulations were optimized by the viscosity measurement and in vitro gelation study. Selected formulations were evaluated for in vitro drug release profile and indicated sustain drug release over a period of 10 h. Effect of sterilization on drug content, pH, clarity, and viscosity were also evaluated. Finally, we concluded that by using this type of combination system, we could reduce not only the concentration of individual polymers but also the side effects without compromising the in vitro gelling capacity as well as overall rheology of the system.

Keywords: Carbopol 940; Pluronic F 127; cromolyn sodium; in situ gelation; ophthalmic delivery

References

1. J Ocul Pharmacol. 1986 Winter;2(1):67-108 - PubMed
2. J Control Release. 2000 Dec 3;69(3):379-88 - PubMed
3. Arch Ophthalmol. 2001 Mar;119(3):338-42 - PubMed
4. J Pharm Sci. 1985 Apr;74(4):399-405 - PubMed
5. J Pharm Sci. 1979 Jun;68(6):673-84 - PubMed

Publication Types

• Journal Article